1534
Children with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
 Children with acute lymphoblastic leukemia (ALL): Subject; Children: Subject.Age; cerebral thrombosis or hemorrhage: Effect; coagulation protein deficiencies: Effect; L-asparaginase: Treatment; L-asparaginase: Treatment.Drug; acute lymphoblastic leukemia (ALL): Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Children with acute lymphoblastic leukemia (ALL): Subject; Children: Subject.Age; cerebral thrombosis or hemorrhage: Effect; coagulation protein deficiencies: Effect; L-asparaginase: Treatment; L-asparaginase: Treatment.Drug; acute lymphoblastic leukemia (ALL): Treatment.Disorder